-
Novartis Pharmaceuticals rose over 150% in the US stock market before trading
Securities Times e-Company News: Novartis Pharmaceuticals rose over 150% in the US stock market, and the company has reached a billion dollar partnership with Sanofi. -
Novartis Pharmaceuticals rose over 200% in the US stock market before trading
Novartis Pharmaceuticals rose over 200% in the US stock market, and the company has reached a multi billion dollar partnership with Sanofi. -
Does Novo Nordisk and Novartis accelerate the peak period of cross-border pharmaceutical companies entering the acquisition market?
Recently, multinational pharmaceutical companies have launched another massive acquisition case, attracting global attention. On February 5th, Novo Nordisk announced that its controlling shareholder, ... -
Multinational pharmaceutical company sees Chinese innovative pharmaceutical company Novartis announces acquisition of Sinopharm Pharmaceuticals
Recently, multinational pharmaceutical giant Novartis announced an agreement to acquire Sinovac Pharmaceuticals, strengthening its presence in the field of kidney disease. Xinruinuo Pharmaceuticals i ...